Get started
Author

Youjin Kim

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC
2018 · Youjin Kim, Boram Lee, et al. · Journal of Thoracic Oncology · 174
PDF
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
2018 · Youjin Kim, Se-Hoon Lee, et al. · Cancer Research and Treatment · 101
PDF
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor
2019 · Youjin Kim, Chu Hyun Kim, et al. · Journal of Thoracic Oncology · 97
PDF
Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance
2018 · Hee Kyung Kim, Kyung Hee Park, et al. · Cancer Research and Treatment · 92
PDF
MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
2020 · Jiae Koh, Youjin Kim, et al. · European Journal of Immunology · 90
PDF
Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma
2019 · Sehhoon Park, Joon Ho Shim, et al. · Lung Cancer · 63
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
2018 · Seonggyu Byeon, Youjin Kim, et al. · Cancer Research and Treatment · 54
PDF
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication
2018 · Hansang Lee, Ho Yun Lee, et al. · Journal of Thoracic Oncology · 52
PDF
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer
2019 · Kangkook Lee, Youjin Kim, et al. · Lung Cancer · 49
Clinical features and prognosis of breast cancer with gastric metastasis
2018 · Joohyun Hong, Youjin Kim, et al. · Oncology Letters · 35
PDF
Plasmacytoid dendritic cell neoplasms
2023 · Yoo Jin Lee, Youjin Kim, et al. · Blood Research · 26
PDF
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
2017 · Jung Eun Kim, Youjin Kim, et al. · Oncotarget · 26
PDF
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer
2021 · Bo Mi Ku, Youjin Kim, et al. · European Journal of Immunology · 25
PDF
T-large granular lymphocytic leukemia
2023 · Sang Hyuk Park, Yoo Jin Lee, et al. · Blood Research · 22
PDF
Hyperprogression after immunotherapy: Clinical implication and genomic alterations in advanced non-small cell lung cancer patients (NSCLC).
2018 · Youjin Kim, Chu Hyun Kim, et al. · Journal of Clinical Oncology · 21
Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea
2020 · Jun Ho Jang, Youjin Kim, et al. · PLoS Medicine · 19
PDF
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma
2018 · Jiyun Lee, Hyun Ae Jung, et al. · Lung Cancer · 16
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial
2018 · Sung Won Lim, Sehhoon Park, et al. · Lung Cancer · 15
Efficient one-pot synthesis of magnetic MIL-100(Fe) using nitric acid without additional Fe ion addition and adsorption behavior of charged organic compounds
2022 · Hyeonho Lee, David Inhyuk Kim, et al. · Chemosphere · 13
High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer
2019 · Youjin Kim, Sun-ju Byeon, et al. · Journal of Cancer · 12
PDF
Phase II trial of nintedanib in patients with recurrent or metastatic salivary gland cancer: A multicenter phase II study.
2016 · Youjin Kim, Su Jin Lee, et al. · Journal of Clinical Oncology · 6
Effect of NaOCl and ClO2 on seawater desalination using reverse osmosis with cartridge filtration as the pretreatment during the algal bloom
2023 · Youjin Kim, Paula Jungwon Choi, et al. · Chemosphere · 4
The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation
2022 · Sook-Kyoung Heo, Eui-Kyu Noh, et al. · BMC Cancer · 4
PDF
Overall survival beyond first-line docetaxel in patients with metastatic castrate-resistant prostate cancer treated with abiraterone acetate or enzalutamide.
2017 · Mi Hwa Heo, Se Hoon Park, et al. · Journal of Clinical Oncology · 3
Identification of FGFR3-TACC3 gene fusion in metastatic gastric cancer
2017 · Youjin Kim, Seung Tae Kim, et al. · Precision and Future Medicine · 2
PDF
Works count: 54
Citation count: 1,028
H-index: 16
I10-index: 20
Year
Topic
Type